Task: Answer the MCQ question.
Query: Which drug exhibits a 7.853% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] CC(=O)NCCn1c(SCC(=O)NCC2CCCO2)nc2ccccc2c1=O
[b] Cc1cc(C)nc(SCc2nnc(SCC(=O)N3CCOCC3)o2)n1
Answer: b. Cc1cc(C)nc(SCc2nnc(SCC(=O)N3CCOCC3)o2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)nc(SCc2nnc(SCC(=O)N3CCOCC3)o2)n1
Cc1cc(C)nc(SCc2nnc(SCC(=O)N3CCOCC3)o2)n1
2-[[5-[(4,6-dimethylpyrimidin-2-yl)sulfanylmethyl]-1,3,4-oxadiazol-2-yl]sulfanyl]-1-morpholin-4-ylethanone